| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis | 97 | 2024 | 1100 | 8.340 |
Why?
|
| Pancreatitis, Chronic | 42 | 2023 | 281 | 4.500 |
Why?
|
| Pancreatitis, Acute Necrotizing | 25 | 2023 | 173 | 3.930 |
Why?
|
| Pancreas | 39 | 2017 | 1677 | 1.840 |
Why?
|
| Acute Disease | 67 | 2024 | 7268 | 1.310 |
Why?
|
| Pancreatic Diseases | 10 | 2022 | 343 | 1.080 |
Why?
|
| Hematocrit | 6 | 2015 | 629 | 1.070 |
Why?
|
| Severity of Illness Index | 33 | 2019 | 15840 | 0.980 |
Why?
|
| Terahertz Spectroscopy | 1 | 2023 | 1 | 0.890 |
Why?
|
| Multiple Organ Failure | 13 | 2019 | 386 | 0.840 |
Why?
|
| Blood Urea Nitrogen | 3 | 2015 | 187 | 0.830 |
Why?
|
| Abdominal Pain | 10 | 2024 | 1063 | 0.730 |
Why?
|
| Pancreatic Juice | 13 | 2017 | 60 | 0.710 |
Why?
|
| Pancreatic Function Tests | 10 | 2017 | 69 | 0.700 |
Why?
|
| Pancreatic Pseudocyst | 10 | 2013 | 110 | 0.610 |
Why?
|
| Pancreatic Ducts | 10 | 2017 | 329 | 0.600 |
Why?
|
| Exocrine Pancreatic Insufficiency | 5 | 2022 | 84 | 0.500 |
Why?
|
| Lipase | 5 | 2024 | 324 | 0.490 |
Why?
|
| Bacterial Infections | 8 | 2021 | 1403 | 0.490 |
Why?
|
| Tomography, X-Ray Computed | 36 | 2021 | 20509 | 0.470 |
Why?
|
| Patient Admission | 6 | 2018 | 1385 | 0.460 |
Why?
|
| Systemic Inflammatory Response Syndrome | 5 | 2017 | 621 | 0.430 |
Why?
|
| Hemoglobins | 2 | 2009 | 1521 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 15 | 2016 | 5349 | 0.430 |
Why?
|
| Pancreatic Cyst | 6 | 2013 | 367 | 0.420 |
Why?
|
| Crohn Disease | 12 | 2016 | 2275 | 0.420 |
Why?
|
| Patient Transfer | 2 | 2010 | 779 | 0.420 |
Why?
|
| Endoscopy, Digestive System | 10 | 2019 | 351 | 0.420 |
Why?
|
| Middle Aged | 136 | 2024 | 220359 | 0.410 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 9 | 2016 | 506 | 0.410 |
Why?
|
| Drainage | 11 | 2021 | 1161 | 0.410 |
Why?
|
| Fluid Therapy | 5 | 2019 | 579 | 0.370 |
Why?
|
| Pancreatitis, Alcoholic | 3 | 2016 | 28 | 0.370 |
Why?
|
| Bicarbonates | 10 | 2015 | 292 | 0.350 |
Why?
|
| Necrosis | 17 | 2016 | 1612 | 0.350 |
Why?
|
| Humans | 237 | 2024 | 760613 | 0.350 |
Why?
|
| Adult | 118 | 2024 | 220007 | 0.340 |
Why?
|
| Hospital Mortality | 5 | 2014 | 5418 | 0.340 |
Why?
|
| Emergency Service, Hospital | 10 | 2024 | 7818 | 0.340 |
Why?
|
| Colitis, Ulcerative | 7 | 2016 | 1919 | 0.330 |
Why?
|
| Male | 152 | 2024 | 359718 | 0.330 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2009 | 16 | 0.330 |
Why?
|
| Pancreatic Stellate Cells | 4 | 2013 | 28 | 0.330 |
Why?
|
| Female | 146 | 2024 | 391246 | 0.310 |
Why?
|
| Aged | 89 | 2024 | 169143 | 0.310 |
Why?
|
| Proteomics | 11 | 2013 | 3817 | 0.310 |
Why?
|
| Alcohol Drinking | 11 | 2020 | 4013 | 0.300 |
Why?
|
| Colonoscopy | 5 | 2016 | 1387 | 0.300 |
Why?
|
| Hospitalization | 7 | 2019 | 10789 | 0.290 |
Why?
|
| Mandibular Condyle | 2 | 2005 | 115 | 0.290 |
Why?
|
| Radiography, Interventional | 4 | 2009 | 1112 | 0.290 |
Why?
|
| Smoking | 11 | 2019 | 9073 | 0.290 |
Why?
|
| Genetic Fitness | 2 | 2018 | 116 | 0.280 |
Why?
|
| Pain | 8 | 2021 | 5066 | 0.270 |
Why?
|
| Trypsinogen | 3 | 2012 | 84 | 0.270 |
Why?
|
| Carbapenems | 1 | 2007 | 123 | 0.260 |
Why?
|
| Prognathism | 1 | 2005 | 26 | 0.260 |
Why?
|
| Mandibular Advancement | 2 | 2005 | 64 | 0.260 |
Why?
|
| Chromatography, Liquid | 8 | 2013 | 987 | 0.260 |
Why?
|
| Aminosalicylic Acids | 1 | 2005 | 37 | 0.260 |
Why?
|
| Nutritional Support | 1 | 2007 | 172 | 0.260 |
Why?
|
| Proteome | 5 | 2013 | 1855 | 0.250 |
Why?
|
| Cost of Illness | 2 | 2014 | 1940 | 0.250 |
Why?
|
| Proteins | 9 | 2013 | 6029 | 0.250 |
Why?
|
| APACHE | 7 | 2015 | 267 | 0.250 |
Why?
|
| Prognosis | 19 | 2019 | 29661 | 0.240 |
Why?
|
| Diet, Fat-Restricted | 1 | 2007 | 330 | 0.240 |
Why?
|
| Diagnostic Imaging | 6 | 2018 | 3527 | 0.240 |
Why?
|
| Tandem Mass Spectrometry | 9 | 2013 | 1189 | 0.230 |
Why?
|
| Cartilage | 2 | 2005 | 806 | 0.230 |
Why?
|
| Cohort Studies | 24 | 2021 | 41337 | 0.230 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2024 | 49 | 0.230 |
Why?
|
| Malocclusion, Angle Class II | 3 | 1999 | 34 | 0.230 |
Why?
|
| Trypsin | 3 | 2020 | 496 | 0.220 |
Why?
|
| Mycoses | 1 | 2007 | 387 | 0.220 |
Why?
|
| Malocclusion | 4 | 1990 | 131 | 0.220 |
Why?
|
| Common Bile Duct Diseases | 2 | 2016 | 36 | 0.220 |
Why?
|
| Mentors | 1 | 2008 | 661 | 0.210 |
Why?
|
| Multivariate Analysis | 16 | 2022 | 12159 | 0.210 |
Why?
|
| Mass Spectrometry | 5 | 2013 | 2192 | 0.210 |
Why?
|
| Endosonography | 4 | 2017 | 607 | 0.200 |
Why?
|
| Risk Factors | 34 | 2023 | 74333 | 0.200 |
Why?
|
| Early Diagnosis | 3 | 2018 | 1180 | 0.200 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2012 | 1110 | 0.200 |
Why?
|
| Telomere | 2 | 2018 | 934 | 0.190 |
Why?
|
| Vibration | 1 | 2023 | 327 | 0.190 |
Why?
|
| Oligopeptides | 2 | 1997 | 1187 | 0.180 |
Why?
|
| Prospective Studies | 23 | 2024 | 54306 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2016 | 1722 | 0.180 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2013 | 1744 | 0.180 |
Why?
|
| NAD | 1 | 2024 | 609 | 0.170 |
Why?
|
| Point-of-Care Systems | 1 | 2009 | 1204 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 1846 | 0.170 |
Why?
|
| Resuscitation | 2 | 2019 | 661 | 0.170 |
Why?
|
| Protein Array Analysis | 2 | 2012 | 401 | 0.170 |
Why?
|
| Patient Readmission | 6 | 2023 | 3322 | 0.170 |
Why?
|
| Aged, 80 and over | 31 | 2021 | 58980 | 0.170 |
Why?
|
| ROC Curve | 7 | 2015 | 3568 | 0.170 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2014 | 446 | 0.170 |
Why?
|
| Dietary Fats | 1 | 2007 | 1992 | 0.170 |
Why?
|
| Autophagy | 2 | 2024 | 1337 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2021 | 36286 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2018 | 1854 | 0.160 |
Why?
|
| I-kappa B Kinase | 1 | 2020 | 251 | 0.160 |
Why?
|
| Cross Infection | 1 | 2008 | 1434 | 0.160 |
Why?
|
| Tooth Diseases | 2 | 1996 | 74 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 4 | 2013 | 7475 | 0.160 |
Why?
|
| Extraoral Traction Appliances | 2 | 1988 | 9 | 0.150 |
Why?
|
| Sick Leave | 2 | 2017 | 105 | 0.150 |
Why?
|
| United States | 23 | 2023 | 72448 | 0.150 |
Why?
|
| Pancreatic Extracts | 1 | 1997 | 6 | 0.150 |
Why?
|
| Retrospective Studies | 36 | 2023 | 80345 | 0.150 |
Why?
|
| Chi-Square Distribution | 6 | 2014 | 3465 | 0.150 |
Why?
|
| Jejunal Diseases | 2 | 1989 | 46 | 0.150 |
Why?
|
| Orthodontic Appliances, Removable | 2 | 1988 | 30 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2018 | 2698 | 0.150 |
Why?
|
| Patient Compliance | 3 | 2014 | 2688 | 0.140 |
Why?
|
| Telephone | 1 | 2001 | 624 | 0.140 |
Why?
|
| Catheterization | 3 | 2009 | 1432 | 0.140 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 3763 | 0.140 |
Why?
|
| Chronic Disease | 16 | 2011 | 9288 | 0.140 |
Why?
|
| Logistic Models | 11 | 2019 | 13312 | 0.140 |
Why?
|
| Area Under Curve | 3 | 2015 | 1635 | 0.140 |
Why?
|
| Gastroenterology | 2 | 2001 | 571 | 0.140 |
Why?
|
| Yeasts | 1 | 2018 | 279 | 0.140 |
Why?
|
| Genome, Fungal | 1 | 2018 | 203 | 0.140 |
Why?
|
| Nitrogen | 1 | 2018 | 350 | 0.140 |
Why?
|
| Education, Medical | 1 | 2008 | 1727 | 0.140 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2015 | 867 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 8 | 2019 | 7408 | 0.140 |
Why?
|
| Golgi Apparatus | 1 | 2018 | 404 | 0.140 |
Why?
|
| Length of Stay | 9 | 2023 | 6476 | 0.140 |
Why?
|
| Population Surveillance | 3 | 2016 | 2608 | 0.130 |
Why?
|
| Time Factors | 16 | 2019 | 40139 | 0.130 |
Why?
|
| Monitoring, Physiologic | 2 | 2022 | 1784 | 0.130 |
Why?
|
| Predictive Value of Tests | 8 | 2024 | 15286 | 0.130 |
Why?
|
| Allopurinol | 1 | 1997 | 198 | 0.130 |
Why?
|
| Gastrinoma | 1 | 1996 | 20 | 0.130 |
Why?
|
| Adenoma, Islet Cell | 1 | 1996 | 72 | 0.130 |
Why?
|
| Diagnosis, Differential | 11 | 2015 | 12968 | 0.130 |
Why?
|
| DNA, Fungal | 1 | 2017 | 275 | 0.130 |
Why?
|
| Prader-Willi Syndrome | 1 | 1996 | 76 | 0.130 |
Why?
|
| Schizosaccharomyces | 1 | 2018 | 237 | 0.130 |
Why?
|
| Chemical Precipitation | 2 | 2013 | 176 | 0.130 |
Why?
|
| Immunologic Factors | 1 | 2005 | 1588 | 0.130 |
Why?
|
| Demography | 2 | 2019 | 1650 | 0.130 |
Why?
|
| Unemployment | 1 | 2017 | 209 | 0.120 |
Why?
|
| Endoscopy | 4 | 2015 | 1838 | 0.120 |
Why?
|
| Body Fluids | 3 | 2013 | 319 | 0.120 |
Why?
|
| Subcellular Fractions | 2 | 2013 | 532 | 0.120 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 106 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 1888 | 0.120 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2009 | 517 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2002 | 1489 | 0.120 |
Why?
|
| Disease Progression | 7 | 2020 | 13505 | 0.120 |
Why?
|
| von Hippel-Lindau Disease | 1 | 1995 | 151 | 0.120 |
Why?
|
| Gas Gangrene | 1 | 1994 | 9 | 0.120 |
Why?
|
| Paraffin Embedding | 2 | 2013 | 302 | 0.120 |
Why?
|
| Tissue Fixation | 2 | 2013 | 241 | 0.120 |
Why?
|
| Pleural Effusion | 1 | 1997 | 343 | 0.120 |
Why?
|
| Observer Variation | 3 | 2017 | 2601 | 0.120 |
Why?
|
| Absorptiometry, Photon | 1 | 2020 | 1736 | 0.120 |
Why?
|
| Mitochondria | 2 | 2024 | 3601 | 0.120 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2015 | 190 | 0.120 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 1995 | 146 | 0.110 |
Why?
|
| Infarction | 1 | 1995 | 248 | 0.110 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 1077 | 0.110 |
Why?
|
| Formaldehyde | 2 | 2013 | 358 | 0.110 |
Why?
|
| Young Adult | 21 | 2020 | 58748 | 0.110 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 194 | 0.110 |
Why?
|
| Case-Control Studies | 12 | 2019 | 22052 | 0.110 |
Why?
|
| Orthodontic Wires | 1 | 1993 | 21 | 0.110 |
Why?
|
| Quality of Life | 4 | 2018 | 13308 | 0.110 |
Why?
|
| Orbital Fractures | 2 | 1998 | 109 | 0.110 |
Why?
|
| Cystic Fibrosis | 2 | 2014 | 1274 | 0.110 |
Why?
|
| Sensitivity and Specificity | 10 | 2018 | 14661 | 0.110 |
Why?
|
| Tooth Eruption | 2 | 1990 | 29 | 0.110 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2013 | 109 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 2014 | 575 | 0.100 |
Why?
|
| Amylases | 4 | 1984 | 169 | 0.100 |
Why?
|
| Malocclusion, Angle Class III | 2 | 1996 | 38 | 0.100 |
Why?
|
| Fixatives | 1 | 2012 | 91 | 0.100 |
Why?
|
| Gallstones | 1 | 2015 | 283 | 0.100 |
Why?
|
| Fellowships and Scholarships | 1 | 2001 | 1116 | 0.100 |
Why?
|
| Risk Assessment | 11 | 2019 | 24102 | 0.100 |
Why?
|
| Hepatic Stellate Cells | 1 | 2013 | 119 | 0.100 |
Why?
|
| Colonic Neoplasms | 3 | 2014 | 2526 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2021 | 2618 | 0.100 |
Why?
|
| Two-Dimensional Difference Gel Electrophoresis | 1 | 2011 | 5 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 115 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 2 | 2019 | 1822 | 0.100 |
Why?
|
| Hernia, Ventral | 1 | 1995 | 214 | 0.100 |
Why?
|
| Cyst Fluid | 1 | 2012 | 83 | 0.100 |
Why?
|
| Mesalamine | 2 | 2006 | 136 | 0.100 |
Why?
|
| Extracellular Fluid | 1 | 2013 | 165 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2019 | 2913 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2018 | 4938 | 0.100 |
Why?
|
| Fistula | 1 | 1993 | 214 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2021 | 3215 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2019 | 1096 | 0.090 |
Why?
|
| Image Enhancement | 1 | 2002 | 2881 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8552 | 0.090 |
Why?
|
| Isotonic Solutions | 1 | 2011 | 116 | 0.090 |
Why?
|
| Treatment Outcome | 19 | 2021 | 64981 | 0.090 |
Why?
|
| Follow-Up Studies | 11 | 2016 | 39262 | 0.090 |
Why?
|
| Organelles | 1 | 2013 | 267 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2016 | 643 | 0.090 |
Why?
|
| Immunohistochemistry | 5 | 2019 | 11070 | 0.090 |
Why?
|
| DNA Damage | 2 | 2018 | 2442 | 0.090 |
Why?
|
| Urine | 1 | 1992 | 363 | 0.090 |
Why?
|
| Netherlands | 2 | 2015 | 2213 | 0.090 |
Why?
|
| Cephalometry | 4 | 2005 | 382 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2014 | 630 | 0.090 |
Why?
|
| Odontogenic Cysts | 1 | 1990 | 42 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 2714 | 0.090 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 785 | 0.090 |
Why?
|
| Survival Rate | 5 | 2016 | 12810 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2018 | 1607 | 0.090 |
Why?
|
| Biopsy, Needle | 4 | 2008 | 1630 | 0.090 |
Why?
|
| Octreotide | 1 | 2010 | 153 | 0.090 |
Why?
|
| North America | 3 | 2020 | 1284 | 0.090 |
Why?
|
| Orthodontics, Corrective | 3 | 1999 | 77 | 0.080 |
Why?
|
| Molar | 1 | 1990 | 156 | 0.080 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2009 | 21 | 0.080 |
Why?
|
| Mandibular Diseases | 1 | 1990 | 119 | 0.080 |
Why?
|
| Ileal Diseases | 1 | 1989 | 69 | 0.080 |
Why?
|
| Mucin-2 | 1 | 2009 | 50 | 0.080 |
Why?
|
| Incidence | 5 | 2014 | 21391 | 0.080 |
Why?
|
| Synaptophysin | 1 | 2009 | 139 | 0.080 |
Why?
|
| Life Style | 1 | 2020 | 3898 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2011 | 591 | 0.080 |
Why?
|
| Thrombocytopenia | 2 | 1995 | 1174 | 0.080 |
Why?
|
| Ultrasonography | 6 | 2009 | 5961 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 464 | 0.080 |
Why?
|
| Smoking Cessation | 1 | 2020 | 2064 | 0.080 |
Why?
|
| Constriction, Pathologic | 5 | 2016 | 1098 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2014 | 575 | 0.080 |
Why?
|
| Fractures, Spontaneous | 1 | 2010 | 231 | 0.080 |
Why?
|
| Recurrence | 8 | 2018 | 8483 | 0.080 |
Why?
|
| Radiography | 8 | 2015 | 6965 | 0.080 |
Why?
|
| Maxillary Fractures | 1 | 1988 | 21 | 0.080 |
Why?
|
| Receptor, erbB-2 | 1 | 2019 | 2554 | 0.080 |
Why?
|
| Nicotine | 1 | 2013 | 677 | 0.080 |
Why?
|
| Patient Care Planning | 3 | 2005 | 908 | 0.070 |
Why?
|
| Duodenal Diseases | 3 | 1984 | 99 | 0.070 |
Why?
|
| Pain Measurement | 6 | 2017 | 3527 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 1745 | 0.070 |
Why?
|
| Zollinger-Ellison Syndrome | 1 | 1987 | 13 | 0.070 |
Why?
|
| Prevalence | 6 | 2021 | 15686 | 0.070 |
Why?
|
| Physicians | 2 | 2019 | 4591 | 0.070 |
Why?
|
| Jejunal Neoplasms | 1 | 1987 | 19 | 0.070 |
Why?
|
| Colon | 1 | 1995 | 1788 | 0.070 |
Why?
|
| Isoenzymes | 2 | 1984 | 1690 | 0.070 |
Why?
|
| Bone Density | 1 | 2020 | 3534 | 0.070 |
Why?
|
| Duodenum | 1 | 2010 | 486 | 0.070 |
Why?
|
| Cross-Sectional Studies | 10 | 2020 | 25941 | 0.070 |
Why?
|
| Vitamins | 2 | 2018 | 1634 | 0.070 |
Why?
|
| Sex Factors | 7 | 2017 | 10546 | 0.070 |
Why?
|
| Enzyme Replacement Therapy | 2 | 2022 | 79 | 0.070 |
Why?
|
| Forecasting | 1 | 2016 | 2931 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 3725 | 0.070 |
Why?
|
| Pennsylvania | 1 | 2008 | 615 | 0.070 |
Why?
|
| Cysts | 1 | 1992 | 683 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2013 | 10185 | 0.070 |
Why?
|
| Classification | 2 | 2007 | 127 | 0.070 |
Why?
|
| Calculi | 1 | 1987 | 49 | 0.070 |
Why?
|
| Cytokines | 2 | 2012 | 7344 | 0.070 |
Why?
|
| Thioguanine | 1 | 2006 | 44 | 0.070 |
Why?
|
| Vitamin D | 1 | 2020 | 3291 | 0.070 |
Why?
|
| Temporomandibular Joint | 2 | 2005 | 196 | 0.070 |
Why?
|
| Obesity | 4 | 2019 | 12919 | 0.070 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 2 | 2020 | 30 | 0.070 |
Why?
|
| Chromatids | 1 | 2006 | 63 | 0.070 |
Why?
|
| Malocclusion, Angle Class I | 1 | 1986 | 11 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1273 | 0.070 |
Why?
|
| Algorithms | 5 | 2014 | 13982 | 0.070 |
Why?
|
| Hospital Charges | 1 | 2008 | 359 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2018 | 2668 | 0.070 |
Why?
|
| Orthodontic Appliance Design | 2 | 1999 | 53 | 0.070 |
Why?
|
| Fecal Impaction | 1 | 1986 | 32 | 0.070 |
Why?
|
| Tomography, X-Ray | 1 | 2005 | 60 | 0.070 |
Why?
|
| Review Literature as Topic | 2 | 2019 | 350 | 0.070 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1987 | 128 | 0.060 |
Why?
|
| Gastrointestinal Agents | 1 | 2010 | 509 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2008 | 428 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2010 | 707 | 0.060 |
Why?
|
| Health Care Surveys | 4 | 2014 | 2435 | 0.060 |
Why?
|
| Tooth Root | 1 | 1986 | 162 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 4371 | 0.060 |
Why?
|
| Intubation, Gastrointestinal | 2 | 1986 | 166 | 0.060 |
Why?
|
| Research | 2 | 2008 | 1974 | 0.060 |
Why?
|
| Paracentesis | 1 | 2005 | 98 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 150 | 0.060 |
Why?
|
| Intussusception | 1 | 1986 | 115 | 0.060 |
Why?
|
| Comorbidity | 3 | 2019 | 10553 | 0.060 |
Why?
|
| Incisor | 1 | 1986 | 174 | 0.060 |
Why?
|
| Skin Diseases | 2 | 1993 | 1089 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1974 | 0.060 |
Why?
|
| Cholestasis | 1 | 1988 | 377 | 0.060 |
Why?
|
| Gastric Fistula | 2 | 1984 | 73 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2010 | 5075 | 0.060 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2005 | 62 | 0.060 |
Why?
|
| Azathioprine | 1 | 2006 | 356 | 0.060 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 342 | 0.060 |
Why?
|
| Adolescent | 20 | 2019 | 87809 | 0.060 |
Why?
|
| Mediastinal Cyst | 1 | 1984 | 29 | 0.060 |
Why?
|
| Health Resources | 1 | 2011 | 935 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 11902 | 0.060 |
Why?
|
| Patient Discharge | 5 | 2019 | 3474 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4108 | 0.060 |
Why?
|
| Waiting Lists | 1 | 2009 | 763 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2024 | 23374 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 3985 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 12289 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3835 | 0.060 |
Why?
|
| Pylorus | 1 | 1984 | 86 | 0.060 |
Why?
|
| Metabolomics | 1 | 2013 | 1628 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 785 | 0.060 |
Why?
|
| Employment | 1 | 2010 | 1112 | 0.060 |
Why?
|
| Memantine | 1 | 2024 | 105 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 4555 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1881 | 0.050 |
Why?
|
| Ileal Neoplasms | 1 | 1982 | 20 | 0.050 |
Why?
|
| Intestinal Fistula | 1 | 1984 | 143 | 0.050 |
Why?
|
| Superoxides | 1 | 2024 | 387 | 0.050 |
Why?
|
| Self Report | 4 | 2019 | 3711 | 0.050 |
Why?
|
| Cecal Neoplasms | 1 | 1982 | 26 | 0.050 |
Why?
|
| Debridement | 1 | 2005 | 492 | 0.050 |
Why?
|
| Cell Line | 5 | 2019 | 15620 | 0.050 |
Why?
|
| Mutation | 6 | 2018 | 29957 | 0.050 |
Why?
|
| Maxilla | 2 | 1996 | 491 | 0.050 |
Why?
|
| Histiocytic Disorders, Malignant | 1 | 2002 | 14 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3765 | 0.050 |
Why?
|
| Vertical Dimension | 2 | 1996 | 33 | 0.050 |
Why?
|
| Antioxidants | 1 | 2010 | 1667 | 0.050 |
Why?
|
| Duodenal Obstruction | 1 | 1982 | 25 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2299 | 0.050 |
Why?
|
| Cholecystectomy | 2 | 2019 | 406 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 2282 | 0.050 |
Why?
|
| Adenoma | 1 | 2013 | 2148 | 0.050 |
Why?
|
| Neutrophils | 1 | 2015 | 3767 | 0.050 |
Why?
|
| Diarrhea | 3 | 2010 | 1319 | 0.050 |
Why?
|
| Histiocytes | 1 | 2002 | 98 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2005 | 580 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4716 | 0.050 |
Why?
|
| Bone Resorption | 1 | 2005 | 720 | 0.050 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 1995 | 343 | 0.050 |
Why?
|
| Reye Syndrome | 1 | 1981 | 28 | 0.050 |
Why?
|
| Leukocytes | 1 | 2010 | 2027 | 0.050 |
Why?
|
| Abscess | 2 | 2004 | 605 | 0.050 |
Why?
|
| Nausea | 2 | 2010 | 678 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2005 | 409 | 0.050 |
Why?
|
| Publishing | 1 | 2008 | 836 | 0.050 |
Why?
|
| Vomiting | 2 | 2010 | 650 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2250 | 0.050 |
Why?
|
| Mandible | 1 | 2005 | 750 | 0.050 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 1007 | 0.050 |
Why?
|
| Regression Analysis | 3 | 1998 | 6359 | 0.050 |
Why?
|
| Inflammation | 2 | 2018 | 10755 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2010 | 1601 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 12628 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 1189 | 0.040 |
Why?
|
| Pancreatectomy | 4 | 2016 | 810 | 0.040 |
Why?
|
| Escherichia coli Infections | 2 | 1995 | 523 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10826 | 0.040 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 475 | 0.040 |
Why?
|
| Postoperative Complications | 6 | 2014 | 15679 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2782 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2018 | 1167 | 0.040 |
Why?
|
| Terminology as Topic | 3 | 2014 | 1535 | 0.040 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 6853 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15790 | 0.040 |
Why?
|
| Health Status | 1 | 2013 | 4082 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2005 | 2647 | 0.040 |
Why?
|
| Stomach | 3 | 1969 | 694 | 0.040 |
Why?
|
| Linear Models | 3 | 2017 | 5877 | 0.040 |
Why?
|
| Orthodontic Appliances, Functional | 1 | 1999 | 12 | 0.040 |
Why?
|
| Ribosomal Proteins | 2 | 2011 | 363 | 0.040 |
Why?
|
| Child | 12 | 2020 | 79799 | 0.040 |
Why?
|
| Morbidity | 2 | 1997 | 1765 | 0.040 |
Why?
|
| Range of Motion, Articular | 1 | 2005 | 1583 | 0.040 |
Why?
|
| Stents | 2 | 2002 | 3303 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 2716 | 0.040 |
Why?
|
| Cell Death | 1 | 2024 | 1671 | 0.040 |
Why?
|
| Biliary Tract Diseases | 1 | 2019 | 157 | 0.040 |
Why?
|
| Retinol-Binding Proteins | 1 | 2018 | 67 | 0.040 |
Why?
|
| Mental Health | 1 | 2013 | 3213 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1986 | 1131 | 0.040 |
Why?
|
| Liver Diseases | 3 | 2015 | 1302 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2022 | 8022 | 0.040 |
Why?
|
| Jejunum | 3 | 1987 | 471 | 0.040 |
Why?
|
| Axons | 1 | 2006 | 1672 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2010 | 2041 | 0.040 |
Why?
|
| Hospitals, Teaching | 2 | 2015 | 1166 | 0.040 |
Why?
|
| Diploidy | 1 | 2018 | 132 | 0.040 |
Why?
|
| Motivation | 3 | 2014 | 1993 | 0.040 |
Why?
|
| Cleft Palate | 2 | 1995 | 587 | 0.040 |
Why?
|
| Osteocalcin | 1 | 2018 | 274 | 0.040 |
Why?
|
| Spores, Fungal | 1 | 2018 | 90 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2015 | 20080 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2005 | 6498 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2012 | 6552 | 0.040 |
Why?
|
| Gold Alloys | 1 | 1996 | 6 | 0.040 |
Why?
|
| Inpatients | 1 | 2009 | 2580 | 0.040 |
Why?
|
| Naphthyridines | 1 | 2018 | 141 | 0.040 |
Why?
|
| Metal Ceramic Alloys | 1 | 1996 | 14 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11345 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2024 | 1612 | 0.040 |
Why?
|
| Governing Board | 1 | 1997 | 50 | 0.040 |
Why?
|
| Sirolimus | 1 | 2024 | 1547 | 0.040 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2018 | 178 | 0.030 |
Why?
|
| Dental Occlusion | 1 | 1996 | 54 | 0.030 |
Why?
|
| Tooth Crown | 1 | 1996 | 61 | 0.030 |
Why?
|
| Face | 2 | 1997 | 1017 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 1997 | 398 | 0.030 |
Why?
|
| Prealbumin | 1 | 2018 | 222 | 0.030 |
Why?
|
| Dental Enamel | 1 | 1996 | 60 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 2896 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 1998 | 302 | 0.030 |
Why?
|
| Dental Porcelain | 1 | 1996 | 68 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 1869 | 0.030 |
Why?
|
| Osteotomy, Le Fort | 1 | 1996 | 93 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 1997 | 524 | 0.030 |
Why?
|
| Medical Audit | 1 | 2017 | 453 | 0.030 |
Why?
|
| Joints | 1 | 1997 | 321 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2019 | 727 | 0.030 |
Why?
|
| Crowns | 1 | 1996 | 155 | 0.030 |
Why?
|
| Meiosis | 1 | 2018 | 328 | 0.030 |
Why?
|
| Europe | 1 | 2002 | 3441 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2019 | 829 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2015 | 45 | 0.030 |
Why?
|
| Jaundice | 1 | 2016 | 97 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2018 | 499 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 1997 | 408 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2015 | 108 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 1894 | 0.030 |
Why?
|
| Gastroscopy | 2 | 1984 | 209 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 21029 | 0.030 |
Why?
|
| Orbit | 1 | 1998 | 446 | 0.030 |
Why?
|
| Graft Survival | 1 | 2005 | 3795 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2015 | 106 | 0.030 |
Why?
|
| Dental Prosthesis Design | 1 | 1996 | 264 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 17790 | 0.030 |
Why?
|
| New England | 2 | 2011 | 1050 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2015 | 80 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2015 | 133 | 0.030 |
Why?
|
| Calgranulin B | 1 | 2015 | 86 | 0.030 |
Why?
|
| Hospitals | 2 | 2023 | 3928 | 0.030 |
Why?
|
| Animals | 11 | 2020 | 167960 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 1998 | 682 | 0.030 |
Why?
|
| Ankle | 1 | 1997 | 350 | 0.030 |
Why?
|
| Hyperlipidemias | 2 | 2017 | 782 | 0.030 |
Why?
|
| Cell Movement | 1 | 2006 | 5206 | 0.030 |
Why?
|
| Cell Survival | 1 | 2024 | 5797 | 0.030 |
Why?
|
| Klebsiella Infections | 1 | 1995 | 147 | 0.030 |
Why?
|
| Intestinal Obstruction | 2 | 1995 | 434 | 0.030 |
Why?
|
| Enterococcus faecalis | 1 | 1995 | 247 | 0.030 |
Why?
|
| Creatinine | 1 | 1979 | 1904 | 0.030 |
Why?
|
| Chlorides | 2 | 2014 | 663 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9406 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2024 | 4089 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 3607 | 0.030 |
Why?
|
| Osteotomy | 2 | 1998 | 836 | 0.030 |
Why?
|
| Gastrostomy | 1 | 1996 | 321 | 0.030 |
Why?
|
| Boston | 3 | 2013 | 9278 | 0.030 |
Why?
|
| Age Factors | 4 | 2017 | 18413 | 0.030 |
Why?
|
| Collagen Type VI | 1 | 2013 | 25 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1993 | 78 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2007 | 2942 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2017 | 9716 | 0.030 |
Why?
|
| Mucins | 1 | 1996 | 568 | 0.030 |
Why?
|
| Lymphoma | 2 | 2002 | 1899 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 3386 | 0.030 |
Why?
|
| Dental Alloys | 1 | 1993 | 29 | 0.030 |
Why?
|
| Rectal Fistula | 1 | 1993 | 75 | 0.030 |
Why?
|
| Rubber | 1 | 1993 | 47 | 0.030 |
Why?
|
| Placebos | 1 | 1997 | 1668 | 0.030 |
Why?
|
| Toxemia | 1 | 1992 | 14 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4167 | 0.030 |
Why?
|
| Orthodontic Brackets | 1 | 1993 | 28 | 0.030 |
Why?
|
| Secretory Rate | 3 | 1971 | 81 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3302 | 0.030 |
Why?
|
| Centrifugation | 1 | 2013 | 122 | 0.030 |
Why?
|
| Ultracentrifugation | 1 | 2013 | 183 | 0.030 |
Why?
|
| Exanthema | 1 | 1997 | 504 | 0.030 |
Why?
|
| Maxillofacial Development | 1 | 1993 | 87 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2013 | 163 | 0.030 |
Why?
|
| Shock | 2 | 1992 | 317 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 2505 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 1979 | 831 | 0.030 |
Why?
|
| Alcoholism | 4 | 1995 | 1961 | 0.030 |
Why?
|
| Genotype | 2 | 2019 | 12957 | 0.030 |
Why?
|
| Paranasal Sinus Diseases | 1 | 1993 | 121 | 0.030 |
Why?
|
| Nickel | 1 | 1993 | 128 | 0.030 |
Why?
|
| Chemical Fractionation | 1 | 2012 | 62 | 0.030 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2012 | 27 | 0.030 |
Why?
|
| Enterococcus | 1 | 1993 | 160 | 0.030 |
Why?
|
| Spain | 1 | 2013 | 488 | 0.030 |
Why?
|
| Remission Induction | 2 | 2010 | 2392 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 1 | 1993 | 245 | 0.030 |
Why?
|
| Phenotype | 2 | 2024 | 16548 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2005 | 3598 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 5325 | 0.020 |
Why?
|
| Calcinosis | 3 | 2016 | 1476 | 0.020 |
Why?
|
| Social Support | 1 | 2001 | 2145 | 0.020 |
Why?
|
| Maxillary Sinus | 1 | 1993 | 180 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 1997 | 2061 | 0.020 |
Why?
|
| Uric Acid | 1 | 1997 | 807 | 0.020 |
Why?
|
| Plasma Substitutes | 1 | 2011 | 57 | 0.020 |
Why?
|
| Cystadenoma, Serous | 1 | 2012 | 100 | 0.020 |
Why?
|
| Watchful Waiting | 1 | 2016 | 510 | 0.020 |
Why?
|
| Temperature | 1 | 2018 | 2221 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 435 | 0.020 |
Why?
|
| Atrophy | 1 | 2016 | 1626 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 532 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 2421 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2011 | 223 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1997 | 1440 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2002 | 2725 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 1996 | 1832 | 0.020 |
Why?
|
| Acetazolamide | 1 | 1971 | 96 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1997 | 1296 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1433 | 0.020 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2010 | 103 | 0.020 |
Why?
|
| Urinalysis | 1 | 2013 | 368 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1993 | 577 | 0.020 |
Why?
|
| Acetone | 1 | 2010 | 44 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2254 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2020 | 10442 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2018 | 1398 | 0.020 |
Why?
|
| Documentation | 1 | 1997 | 893 | 0.020 |
Why?
|
| Genes, ras | 1 | 2013 | 654 | 0.020 |
Why?
|
| Root Resorption | 1 | 1990 | 44 | 0.020 |
Why?
|
| Autonomic Nerve Block | 1 | 2010 | 81 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4356 | 0.020 |
Why?
|
| Intensive Care Units | 2 | 2016 | 3736 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 3620 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1673 | 0.020 |
Why?
|
| Titanium | 1 | 1993 | 484 | 0.020 |
Why?
|
| Diabetes Mellitus | 3 | 2018 | 5890 | 0.020 |
Why?
|
| Health | 1 | 2013 | 396 | 0.020 |
Why?
|
| Peptic Ulcer | 3 | 1984 | 219 | 0.020 |
Why?
|
| Contrast Media | 3 | 2011 | 5305 | 0.020 |
Why?
|
| Reproduction | 1 | 2014 | 646 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 887 | 0.020 |
Why?
|
| Computational Biology | 2 | 2012 | 3505 | 0.020 |
Why?
|
| Adenoviridae | 4 | 1966 | 1084 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1741 | 0.020 |
Why?
|
| Syndrome | 1 | 1995 | 3280 | 0.020 |
Why?
|
| Absenteeism | 1 | 2011 | 250 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 1990 | 516 | 0.020 |
Why?
|
| Cytodiagnosis | 1 | 2013 | 442 | 0.020 |
Why?
|
| Secretin | 6 | 1975 | 57 | 0.020 |
Why?
|
| Digestive System Diseases | 1 | 2010 | 151 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 1990 | 279 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2038 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 2418 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1979 | 2093 | 0.020 |
Why?
|
| Tongue | 1 | 1992 | 404 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 499 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 566 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 2417 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 1544 | 0.020 |
Why?
|
| Apoptosis | 1 | 2024 | 9497 | 0.020 |
Why?
|
| India | 2 | 1994 | 2336 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 1788 | 0.020 |
Why?
|
| Gastric Mucosa | 2 | 1969 | 599 | 0.020 |
Why?
|
| Electronics, Medical | 1 | 1987 | 72 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18137 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2018 | 12914 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3618 | 0.020 |
Why?
|
| Protons | 1 | 2013 | 1114 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2821 | 0.020 |
Why?
|
| Massachusetts | 2 | 2010 | 8803 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 788 | 0.020 |
Why?
|
| Vasopressins | 1 | 1968 | 355 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2754 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1992 | 820 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 1997 | 12427 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2011 | 1167 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2011 | 968 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7593 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2001 | 4446 | 0.020 |
Why?
|
| Viral Vaccines | 3 | 1966 | 596 | 0.020 |
Why?
|
| Rats | 2 | 2013 | 23709 | 0.020 |
Why?
|
| Health Services Accessibility | 2 | 2014 | 5397 | 0.020 |
Why?
|
| Metabolome | 1 | 2013 | 982 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1343 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 17624 | 0.020 |
Why?
|
| Office Visits | 1 | 2010 | 597 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1990 | 1089 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 3613 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2018 | 3392 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 458 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2006 | 233 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7805 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 2000 | 6316 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4263 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1987 | 941 | 0.020 |
Why?
|
| Neurons | 1 | 2024 | 9424 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2008 | 1578 | 0.020 |
Why?
|
| Computer Simulation | 1 | 1998 | 6218 | 0.020 |
Why?
|
| Societies, Medical | 1 | 1997 | 3905 | 0.020 |
Why?
|
| Palliative Care | 1 | 2000 | 3607 | 0.010 |
Why?
|
| Exons | 1 | 2010 | 2389 | 0.010 |
Why?
|
| Alveolar Process | 1 | 1986 | 294 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 830 | 0.010 |
Why?
|
| Tooth | 1 | 1986 | 208 | 0.010 |
Why?
|
| Duodenoscopy | 1 | 1984 | 45 | 0.010 |
Why?
|
| Fibrosis | 1 | 2011 | 2042 | 0.010 |
Why?
|
| England | 1 | 1985 | 526 | 0.010 |
Why?
|
| Colonic Diseases | 1 | 1986 | 200 | 0.010 |
Why?
|
| France | 1 | 1985 | 511 | 0.010 |
Why?
|
| Xenopus | 1 | 2006 | 717 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8512 | 0.010 |
Why?
|
| Duodenal Ulcer | 1 | 1984 | 121 | 0.010 |
Why?
|
| Pyloric Antrum | 1 | 1984 | 66 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2049 | 0.010 |
Why?
|
| Ethanol | 1 | 2010 | 1323 | 0.010 |
Why?
|
| Physician's Role | 1 | 2011 | 918 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2013 | 2907 | 0.010 |
Why?
|
| Intestinal Diseases | 2 | 1984 | 506 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16932 | 0.010 |
Why?
|
| Cecum | 1 | 1984 | 232 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2011 | 1826 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1992 | 1669 | 0.010 |
Why?
|
| Needs Assessment | 1 | 2009 | 1139 | 0.010 |
Why?
|
| Internationality | 1 | 2008 | 1004 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1991 | 1231 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1984 | 229 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4571 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14494 | 0.010 |
Why?
|
| Vagotomy | 1 | 1982 | 83 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1987 | 1666 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3709 | 0.010 |
Why?
|
| Mice | 3 | 2015 | 81209 | 0.010 |
Why?
|
| Pediatrics | 1 | 2017 | 3586 | 0.010 |
Why?
|
| Scleroderma, Systemic | 1 | 1986 | 344 | 0.010 |
Why?
|
| Bone Transplantation | 2 | 1998 | 922 | 0.010 |
Why?
|
| Genomics | 1 | 2018 | 5795 | 0.010 |
Why?
|
| Models, Biological | 1 | 2018 | 9468 | 0.010 |
Why?
|
| Ileum | 1 | 1984 | 555 | 0.010 |
Why?
|
| Pain, Intractable | 1 | 1982 | 132 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2017 | 42056 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2001 | 369 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1990 | 2255 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2006 | 728 | 0.010 |
Why?
|
| Rectum | 1 | 1986 | 895 | 0.010 |
Why?
|
| Adenoviridae Infections | 3 | 1966 | 93 | 0.010 |
Why?
|
| Antibodies | 2 | 1966 | 2421 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1997 | 10343 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2020 | 12102 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2010 | 1424 | 0.010 |
Why?
|
| Ileostomy | 2 | 1979 | 120 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2006 | 3105 | 0.010 |
Why?
|
| Duodenoscopes | 1 | 2000 | 43 | 0.010 |
Why?
|
| Peptides | 1 | 2012 | 4354 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14374 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2013 | 3841 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2006 | 866 | 0.010 |
Why?
|
| Equipment Design | 1 | 1987 | 3520 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 12444 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1979 | 361 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3839 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 1991 | 1941 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1652 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 2558 | 0.010 |
Why?
|
| Leukopenia | 1 | 1979 | 212 | 0.010 |
Why?
|
| Hyperparathyroidism | 2 | 1971 | 339 | 0.010 |
Why?
|
| Drosophila | 1 | 2006 | 1492 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2011 | 5132 | 0.010 |
Why?
|
| Zygomatic Fractures | 1 | 1998 | 35 | 0.010 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 1998 | 53 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 5795 | 0.010 |
Why?
|
| Risk | 1 | 2010 | 9632 | 0.010 |
Why?
|
| Administration, Rectal | 1 | 1997 | 70 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 2935 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1979 | 173 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 2846 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1971 | 1385 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1979 | 681 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2013 | 18955 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2002 | 1870 | 0.010 |
Why?
|
| Denervation | 1 | 1998 | 277 | 0.010 |
Why?
|
| Gastrectomy | 1 | 1982 | 679 | 0.010 |
Why?
|
| Tablets | 1 | 1997 | 149 | 0.010 |
Why?
|
| Enema | 1 | 1997 | 141 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2006 | 1444 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 1699 | 0.010 |
Why?
|
| Budgets | 1 | 1998 | 230 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2007 | 2907 | 0.010 |
Why?
|
| Neutralization Tests | 4 | 1966 | 728 | 0.010 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1976 | 86 | 0.010 |
Why?
|
| Databases as Topic | 1 | 1998 | 474 | 0.010 |
Why?
|
| Orbital Diseases | 1 | 1998 | 178 | 0.010 |
Why?
|
| Abdomen | 1 | 1982 | 1130 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7850 | 0.010 |
Why?
|
| Colectomy | 2 | 1979 | 692 | 0.010 |
Why?
|
| Potassium | 2 | 1971 | 1313 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2005 | 8950 | 0.010 |
Why?
|
| External Fixators | 1 | 1995 | 98 | 0.010 |
Why?
|
| Dogs | 2 | 1971 | 3841 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3448 | 0.010 |
Why?
|
| Immobilization | 1 | 1995 | 230 | 0.010 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1975 | 188 | 0.010 |
Why?
|
| Methods | 1 | 1993 | 1074 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2000 | 2129 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 8010 | 0.010 |
Why?
|
| Antibody Formation | 3 | 1966 | 1400 | 0.010 |
Why?
|
| Bone Plates | 1 | 1995 | 465 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1971 | 185 | 0.010 |
Why?
|
| Calcium | 3 | 1985 | 5725 | 0.010 |
Why?
|
| Hydronephrosis | 2 | 1971 | 271 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 1998 | 1183 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2001 | 2628 | 0.010 |
Why?
|
| Electrolytes | 1 | 1971 | 274 | 0.010 |
Why?
|
| Pancreatic Fistula | 1 | 1971 | 148 | 0.010 |
Why?
|
| Protein Deficiency | 1 | 1970 | 59 | 0.010 |
Why?
|
| Cleft Lip | 1 | 1995 | 504 | 0.010 |
Why?
|
| Antigens | 2 | 1966 | 1447 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1997 | 4035 | 0.010 |
Why?
|
| Exocrine Glands | 1 | 1969 | 46 | 0.010 |
Why?
|
| Acidosis | 1 | 1971 | 268 | 0.010 |
Why?
|
| Ureteral Obstruction | 1 | 1971 | 292 | 0.010 |
Why?
|
| Diet Therapy | 1 | 1970 | 151 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 9591 | 0.000 |
Why?
|
| Infant | 1 | 2010 | 36053 | 0.000 |
Why?
|
| Thrombophlebitis | 1 | 1969 | 289 | 0.000 |
Why?
|
| Gastric Acidity Determination | 1 | 1967 | 56 | 0.000 |
Why?
|
| Pituitary Diseases | 1 | 1969 | 135 | 0.000 |
Why?
|
| Cholecystokinin | 3 | 1975 | 117 | 0.000 |
Why?
|
| Carbohydrate Metabolism | 1 | 1969 | 262 | 0.000 |
Why?
|
| Adrenal Gland Diseases | 1 | 1969 | 141 | 0.000 |
Why?
|
| Stomach Diseases | 1 | 1969 | 133 | 0.000 |
Why?
|
| Patient Selection | 1 | 1998 | 4279 | 0.000 |
Why?
|
| Histamine | 1 | 1967 | 498 | 0.000 |
Why?
|
| Pregnancy | 1 | 2007 | 29746 | 0.000 |
Why?
|
| Thyroid Diseases | 1 | 1969 | 386 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1976 | 4902 | 0.000 |
Why?
|
| Vasoconstrictor Agents | 1 | 1969 | 651 | 0.000 |
Why?
|
| Bone Diseases | 1 | 1969 | 418 | 0.000 |
Why?
|
| Peptide Hydrolases | 3 | 1975 | 623 | 0.000 |
Why?
|
| Barium Sulfate | 1 | 1985 | 180 | 0.000 |
Why?
|
| Hydrolases | 1 | 1985 | 146 | 0.000 |
Why?
|
| Gastroesophageal Reflux | 1 | 1971 | 816 | 0.000 |
Why?
|
| Reoperation | 1 | 1993 | 4289 | 0.000 |
Why?
|
| Sodium | 1 | 1968 | 1594 | 0.000 |
Why?
|
| Hypercalcemia | 1 | 1985 | 421 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1997 | 11152 | 0.000 |
Why?
|
| Melanoma | 1 | 2000 | 5697 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 1975 | 0.000 |
Why?
|
| Skin Neoplasms | 1 | 2000 | 5799 | 0.000 |
Why?
|
| Iron | 1 | 1969 | 1786 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1969 | 1902 | 0.000 |
Why?
|
| Immunization | 1 | 1964 | 1227 | 0.000 |
Why?
|
| Angiography | 1 | 1985 | 1605 | 0.000 |
Why?
|
| Urography | 2 | 1971 | 312 | 0.000 |
Why?
|
| Dietary Proteins | 2 | 1975 | 949 | 0.000 |
Why?
|
| Vaccination | 1 | 1964 | 3359 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1976 | 13262 | 0.000 |
Why?
|
| Ureteral Diseases | 1 | 1971 | 65 | 0.000 |
Why?
|
| Calorimetry | 1 | 1970 | 129 | 0.000 |
Why?
|
| Ileitis | 1 | 1969 | 39 | 0.000 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1971 | 329 | 0.000 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1965 | 86 | 0.000 |
Why?
|
| Urinary Tract Infections | 1 | 1969 | 814 | 0.000 |
Why?
|
| Regeneration | 1 | 1970 | 1506 | 0.000 |
Why?
|
| Colitis | 1 | 1969 | 1229 | 0.000 |
Why?
|